Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Allakos reports Phase 1 failure, lays off 75% of staff: The biotech said AK006 did not produce a clinical benefit in patients ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

These are unquestionably serious issues, but Merck remains a top stock to buy and hold, at least for investors focused on the long game. Here's why. Merck's Keytruda generates over $20 billion in ...

A significant milestone was reached on Friday afternoon with the opening of the second completed section of the Monon South ...

Allakos is throwing in the towel. After seeing phase 1 data in hives, the biotech has decided to drop the drug candidate and ...

Eighty bins went to Chain Reaction Bike Hub, which used them for bike parts and other uses. The Cedar Rapids nonprofit ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

Thailand's economy is expected to grow between 3% and 3.5% this year, driven by stimulus measures and strong foreign ...

Against Southampton, Isak managed to display at least seven types of movement — it is this variety which is key to his game.